The article discusses two significant studies related to the management of postoperative inflammatory bowel disease (IBD), focusing on Crohn’s disease…
Browsing: Hot headlines in GI
The article discusses key business moves by three major healthcare companies in the Ambulatory Surgery Center (ASC) sector. READ MORE
Early treatment with infliximab plus an immunomodulator (top-down therapy) showed more frequent steroid-free and surgery-free remission at 1 year compared…
The biotech sector has recently embraced the microbiome, a market driven by affordable genome sequencing and venture capital. These startups…
Key Points: Flat lesions are commonly found during colonoscopies but can be difficult to keep track of, especially in less-than-ideal…
The article highlights five notable women in the field of gastroenterology. These gastroenterologists are making significant contributions to their field,…
The FDA has approved Madrigal Pharmaceuticals’ resmetirom, sold under the brand name Rezdiffra, as the first therapy for MASH, also…
Key Points: The New England Journal of Medicine has published the results of the pivotal BLUE-C study on Cologuard Plus™.…
Conducted by the Regenstrief Institute and Indiana University School of Medicine, the study involved over 21,000 average-risk patients across 186…
Key Points: The acquisition positions Mahana Therapeutics as a global leader in digital treatment solutions for chronic conditions, particularly in…